Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018
February 13 2018 - 9:03AM
InvestorsHub NewsWire
Progressive
Care Breaks Record with Over 23,000 Prescriptions
Filled in January 2018
Miami, FL -- February
13, 2018 -- InvestorsHub NewsWire -- Progressive Care Inc.
(OTCQB:
RXMD), a healthcare services and technology company, announces
record breaking month of January 2018.
PharmCo, LLC filled over
23,000 prescriptions during the month of January, generating $1.8
million in net revenues. Prescriptions filled increased by 34%
compared to the same month last year and by 10% over the last
record breaking month in October 2017. Revenues increased by
approximately 9% as compared to January 2017. The company also
filled over $450,000 worth of prescriptions (not included in Net
Revenues) for 340B entities in January, generating fees to the
pharmacy of just over $20,000. Current growth has been driven by
expansion into Palm Beach County, the digital marketing campaign
with Mass Ventures Corp, proficiency of medication therapy
management and adherence programs, and the visibility of the
pharmacy's 5 star service rating among physicians and patients
throughout South Florida.
"We are thrilled about the
fast start to 2018," stated S. Parikh Mars, CEO. "We are just
beginning to see the results from the groundwork we laid in 2017.
Over the past 12 months, we have strategically positioned ourselves
to take advantage of the changing trends in the healthcare
industry. Today, more physicians than ever before are recognizing
the impact PharmCo and its model has on their bottom line. They are
increasingly seeking out our services to improve patient outcomes
and increase profitability."
Common Shares Issued
and Outstanding:
As of February 13, 2018 the
number shares of common stock issued and outstanding stood at
365,408,769 shares. This amount is net of the number of shares
owned by PharmCo, LLC of 1,718,000. The Company has fully paid off
its first installment from Chicago Venture Partners. The Company
paid approximately $130,000 in cash and $150,000 in stock. Total
shares issued to Chicago Venture Partners was
19,863,662.
Get connected and stay in
touch with us on social media:
Progressive Care
Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive
Care
Progressive Care Inc.
(OTCQB:RXMD),
through its subsidiaries Smart Medical Alliance, Inc. and PharmCo,
LLC, is a South Florida health services organization and provider
of prescription pharmaceuticals, compounded medications, provider
of tele-pharmacy services, the sale of anti-retroviral medications,
medication therapy management (MTM), the supply of prescription
medications to long term care facilities, administration and
practice management, utilization management, quality assurance, EHR
Implementation, billing and coding, and health practice risk
management.
Cautionary Statement
Regarding Forward Looking Statements
Statements contained herein
that are not based upon current or historical fact are
forward-looking in nature and constitute forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. Such
forward-looking statements reflect the Company's expectations about
its future operating results, performance and opportunities that
involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
"anticipate," "believe," "estimate," "upcoming," "plan," "target,"
"intend" and "expect" and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Contact
Armen
Karapetyan
Senior Advisor Business
Development
armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2023 to Apr 2024